Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 2007.00 | 3855.25 | 0.5206 | 0.2653 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 3605.00 | 3855.25 | 0.9351 | 0.9080 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1434.95 | 3774.00 | 3855.25 | 0.9789 | 0.9703 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 1755.00 | 3855.25 | 0.4552 | 0.1517 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3394.00 | 3855.25 | 0.8804 | 0.8290 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6699.00 | 6918.00 | 0.9683 | 0.9511 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 6613.00 | 6918.00 | 0.9559 | 0.9318 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 2808.68 | 6797.00 | 6918.00 | 0.9825 | 0.9731 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 5711.00 | 6918.00 | 0.8255 | 0.7258 |
| BT-20 | Erlotinib | 1 | uM | 9 | 5000.00 | 2808.68 | 5102.00 | 6918.00 | 0.7375 | 0.5825 |
| BT-20 | Lapatinib | 10 | uM | 9 | 5000.00 | 2808.68 | 3545.00 | 6918.00 | 0.5124 | 0.1961 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 6529.00 | 6918.00 | 0.9438 | 0.9130 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 2808.68 | 6841.00 | 6918.00 | 0.9889 | 0.9829 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 6872.00 | 6918.00 | 0.9934 | 0.9898 |
| BT-20 | Lapatinib | 1 | uM | 9 | 5000.00 | 2808.68 | 5994.00 | 6918.00 | 0.8664 | 0.7912 |
| BT-20 | Linsitinib | 10 | uM | 9 | 5000.00 | 2808.68 | 6265.00 | 6918.00 | 0.9056 | 0.8532 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 4894.00 | 6918.00 | 0.7074 | 0.5327 |
| BT-20 | Erlotinib | 10 | uM | 9 | 5000.00 | 2808.68 | 3767.00 | 6918.00 | 0.5445 | 0.2533 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 6994.00 | 6918.00 | 1.0110 | 1.0169 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 6867.00 | 6918.00 | 0.9926 | 0.9887 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 2808.68 | 6522.00 | 6918.00 | 0.9428 | 0.9114 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 5002.00 | 6918.00 | 0.7230 | 0.5586 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 2808.68 | 6974.00 | 6918.00 | 1.0081 | 1.0124 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6709.00 | 6918.00 | 0.9698 | 0.9534 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 2808.68 | 6985.00 | 6918.00 | 1.0097 | 1.0149 |